THE NICKLES GROUP, LLC

Lobbying for BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) · Biotechnology advocacy organization.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $60,000.00 income · posted Jul 20, 2026

Lobbying activity 3

Health Issues

Issues related to pharmacy benefit management reforms. Issues related to vaccine policy. Issues related to the medical countermeasures.

Medicare/Medicaid

Issues related to Most Favored Nation drug pricing.

Trade (domestic/foreign)

Issues related to tariffs.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.